Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04004
Species: Homo sapiens
Position : chr19:15308673-15308842
Year: 2019
Title: Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.
Genome Build: hg19
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: Central Nervous System Leukemia
PMID:  30518632
Tissue: blood / hematopoietic system
Tissue Ontology ID: UBERON:0000178
Cell Source: T-acute lymphoblastic leukemia (T-ALL)
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: TF-binding/chromatin assay; In vivo functional validation; Disease-associated enhancer analysis
Low Throughput Method: ChIP-qPCR/ChIP; RT-qPCR/qPCR; Transgenic/LacZ assay
About Target Gene
Target gene : NOTCH3
About TF
TF name : ZEB2
About Regulatory State
Regulatory State : Repressed
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
ZEB2 TGF_beta_Receptor netpath 220
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer